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OBJECTIVE: To determine the differential expression of inflammatory
mediators in various maternal-fetal compartments and identify
the best non-invasive sampling that can predict the intra-uterine
environment.
STUDY DESIGN: Term, non-laboring patients without major
maternal or fetal complications undergoing cesarean delivery were
asked to provide samples during the immediate pre-operative and
intra-operative period: maternal plasma via venipuncture, 2-3ml
of unstimulated saliva, urine via foley catheter, and cervical and
vaginal secretions via directed speculum examination. Amniotic fluid
was obtained intra-operatively via needle aspiration of the intact
amniotic sac after hysterotomy. These fluids were analyzed for 27
inflammatory mediators using the Bio-Plex array. We compared
the inflammatory mediator profile between all compartments
as well as mediator levels from non-invasive samples (maternal
blood, urine, saliva, vaginal and cervical secretions) with invasive
sampling (amniotic fluid). Correlation among mediators in the various
compartments was determined using Spearman correlation with P
<0.05 required for significance.
RESULTS: Twenty patients were included in this study. Among
the non-invasive compartments studied, none of the inflammatory
mediators were significantly correlated with amniotic fluid. When
comparing cervical secretions to vaginal (posterior fornix) secretions,
25 of the 27 mediators reached a significant correlation, with
correlation co-efficients ranging from 0.460 to 0.943. None of the
remaining non-invasive compartments were significantly correlated
with each other.
CONCLUSION: In term, non-laboring patients, there does not appear
to be correlation of inflammatory mediators between amniotic fluid
and non-invasive maternal-fetal compartments. It remains to be
determined if this finding is the same in preterm pregnancies or in
the presence of labor. There is no difference in the inflammatory
mediator profile between cervical and posterior fornix vaginal
secretions.

Background and Objective:
•	Previous studies have shown that the amniotic fluid cytokine profile
is predictive of pregnancy outcome in patients at risk for preterm
delivery.
• Currently, determination of the intra-amniotic inflammatory melieu
requires invasive testing with its associated risks.
• Perhaps a better understanding of the causes of preterm labor and
effects of treatment can be achieved if the inflammatory status could
be determined in a non-invasive manner.
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Objectives:

Table 1. Timing, Location, and
Collection Method of Samples

•	To determine the differential expression of inflammatory mediators in
various maternal-fetal compartments.
•	To identify the best non-invasive sampling that can predict the intrauterine environment.

Collected at Time of Consent

Methods:
•	Term, non-laboring patients without major maternal or fetal complications
undergoing cesarean delivery were asked to provide samples during the
immediate pre-operative and intra-operative period
•	The timing, location, and collection method of each sample is shown in
Table 1.
•	Samples were analyzed for 27 mediators including cytokines,
chemokines, and growth factors via the Bio-Plex™ Suspension Array
system.
•	We compared the inflammatory mediator profile between all
compartments as well as mediator levels from non-invasive samples
(maternal blood, urine, saliva, vaginal and cervical secretions) with
invasive sampling (amniotic fluid).
•	Correlation among mediators in the various compartments was
determined using Spearman correlation with P <0.05 required for
significance.

Results:
•	Twenty patients were included in this study.
•	Table 2 displays the cytokines which reached a significant correlation
between compartments.
•	Among the non-invasive compartments studied, none of the
inflammatory mediators were significantly correlated with amniotic fluid.
•	When comparing cervical secretions to vaginal (posterior fornix)
secretions, 25 of the 27 mediators reached a significant correlation, with
correlation co-efficients ranging from 0.460 to 0.943.
•	None of the remaining non-invasive compartments were significantly
correlated with each other.

Conclusions:

• In term, non-laboring patients, there does not appear to be correlation
of inflammatory mediators between amniotic fluid and non-invasive
maternal-fetal compartments.
•	It remains to be determined if this finding is the same in preterm
pregnancies or in the presence of labor.
•T
 here is no difference in the inflammatory mediator profile between
cervical and posterior fornix vaginal secretions.

Collection Method

Compartment

Maternal serum

Venipuncture

Maternal saliva

Unstimulated salivation into collection container

Collection in Operating Room after Regional Anesthesia
Maternal urine

Test tube from foley catheter

Cervical secretions

Weck-Cell Sponge via speculum-directed exam

Vaginal fluid

Weck-Cell Sponge via speculum-directed exam
Collected During Cesarean Delivery
Via catheter/needle after hysterotomy prior to rupture
of membranes

Amniotic fluid

Collected Post-operatively
After examination, 2x2 cm portion taken and
transported in culture media to lab for in vitro culture

Placenta

Table 2. Correlation among Cytokines in
Maternal-Fetal Compartments (P <0.05)
Compartment

Amniotic Fluid

Maternal Serum

Urine

Cervical Secretions

Vaginal
Secretions

1

Amniotic Fluid

Maternal Serum

MIP1b

2

3

4

Urine

IL13, PDGF

Cervical
Secretions

IP10, TNFα, VEGF MCP1

Vaginal
Secretions

GCSF, IP10, PDGF,
TNFα

GCSF, Eotaxin, GMCSF, IFNγ,
IL-1b,1ra,2,4,5,6,7,8,9,10,12,
13,15,17,IP10,MCP1,MIP1b,

Eotaxin IL13,
IL15, MIP1a,
TNFα

IFNγ, IL4, IL5, IL17

IL17, FGF

MIP1b, RANTES, VEGF

IL2, IL8, MCP1,
MIP1b

Saliva

IL7

Placental Culture IL5, RANTES

KEY: •
•
•
•

Saliva

Placental Culture

1

2

5

1

IL1ra, IL-2, 4,
10, 13, VEGF

6

25

4

3

2

4

2

IP10, RANTES

 he number of mediators with significant correlations between the compartments is in the upper-right half of table.
T
The names of the mediators which were significantly correlated are in the bottom-left half of the table.
Color coding has been used to aid in matching corresponding boxes.
Interleukin (IL), platelet derived growth factor (PDGF), fibroblast growth factor (FGF), granulocyte colony stimulating factor (GCSF), granulocyte macrophage stimulating factor (GM-CSF), interferon gamma (IFN-γ), inducible protein-10 (IP-10), monocyte
chemotactic protein-1 (MCP-1), macrophage inflammatory protein (MIP), tumor necrosis factor alpha (TNF-α), vascular
endothelial growth factor (VEGF), regulated on activation normal T cell expressed and secreted (RANTES)
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